Author:
Woods Justin D.,Zeidner Joshua F.,Van Deventer Hendrik W.,Jamieson Katarzyna,Matson Melissa,Zhang Jack,Pulley William,Brenizer Tucker,Muss Hyman,Nyrop Kirsten A.,Vohra Sanah N.,Deal Allison M.,Ivanova Anastasia,Foster Matthew C.
Subject
Geriatrics and Gerontology,Oncology
Reference36 articles.
1. National cancer institute SEER stat fact sheets: acute myeloid leukemia (AML),2020
2. Age and acute myeloid leukemia;Appelbaum;Blood,2006
3. Survival for older patients with acute myeloid leukemia: a population-based study;Oran;Haematologica,2012
4. Azacitidine and venetoclax in previously untreated acute myeloid leukemia;DiNardo;N Engl J Med,2020
5. The QUAZAR AML-001 maintenance trial: results of a phase III international, randomized, double-blind, placebo-controlled study of CC-486 (oral formulation of Azacitidine) in patients with acute myeloid leukemia (AML) in first remission;Wei,2019